We are live on ! Find out more
CCMU

Cheyne Capital Management (UK) Portfolio holdings

AUM $27.9M
1-Year Est. Return 36.14%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+36.14%
3 Year Est. Return
+35.61%
5 Year Est. Return
+211.68%
10 Year Est. Return
+661.99%
AUM
$31.5M
AUM Growth
-$25.7M
Cap. Flow
-$27.4M
Cap. Flow %
-86.72%
Top 10 Hldgs %
82.06%
Holding
68
New
8
Increased
1
Reduced
1
Closed
46

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$6.24M
2
SE icon
Sea Limited
SE
+$3.66M
3
OXY icon
Occidental Petroleum
OXY
+$1.88M
4
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$1.76M
5
NTCO
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
+$1.48M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$8.01M
2
EXE
Expand Energy Corp
EXE
+$3.73M
3
RDNT icon
RadNet
RDNT
+$2.1M
4
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
+$1.97M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$1.68M

Sector Composition

Rank Sector Weight
1 Energy 25.16%
2 Healthcare 20.26%
3 Materials 19.45%
4 Consumer Discretionary 14.72%
5 Technology 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VKTX icon
51
Viking Therapeutics
VKTX
$4B
– –
-64,753
Closed -$609K
VTYX
52
DELISTED
Ventyx Biosciences
VTYX
– –
-20,035
Closed -$657K
XENE icon
53
Xenon Pharmaceuticals
XENE
$6.12B
– –
-42,500
Closed -$1.68M
EXE
54
Expand Energy Corp
EXE
$21.5B
– –
-39,506
Closed -$3.73M
SWN
55
DELISTED
Southwestern Energy Company
SWN
– –
-37,000
Closed -$216K
ALPN
56
DELISTED
Alpine Immune Sciences Inc
ALPN
– –
-181,886
Closed -$1.34M
CBAY
57
DELISTED
Cymabay Therapeutics
CBAY
– –
-77,499
Closed -$486K
GRCL
58
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
– –
-98,120
Closed -$226K
MRTX
59
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-6,650
Closed -$301K
PNT
60
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
– –
-127,090
Closed -$926K
FTCH
61
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
– –
-416,500
Closed -$1.97M
SGEN
62
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-8,025
Closed -$1.03M
ICPT
63
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-26,443
Closed -$327K
ISEE
64
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-41,250
Closed -$883K
ALBO
65
DELISTED
Albireo Pharma Inc
ALBO
– –
-13,364
Closed -$289K
CINC
66
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
– –
-67,557
Closed -$830K
ATVI
67
DELISTED
Activision Blizzard
ATVI
– –
-103,136
Closed -$8.01M
1 2
3

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return
TCM
TORQ Capital Management Hong Kong $38.1M AUM 2.81% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
AMC
AKKR Management Company Menlo Park, California $42.5M AUM 123.1% 1-Year Est. Return
P
Pariax Newport Beach, California $44.3M AUM 12.57% 1-Year Est. Return
AOGP
Addition One General Partner New York $45.7M AUM
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return

Cheyne Capital Management (UK)'s Q1 2023 Portfolio in Review

As of Q1 2023, Cheyne Capital Management (UK) held 68 positions worth $31.5M, down 45% from $57.2M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Cheyne Capital Management (UK) withdrew a net $27.4M in Q1 2023, closing 46 positions and reducing 1 holding. Its most notable exit was Activision Blizzard, an estimated $8.01M position sold in full.

By sector, the portfolio is most concentrated in Energy at 25% of assets, up from 20% a quarter earlier, followed by Healthcare and Materials.

Against the trend, Cheyne Capital Management (UK) opened a new position in Eli Lilly worth $6.35M.

  • Cheyne Capital Management (UK)'s largest Q1 2023 buy was Eli Lilly: 18,500 shares worth $6.35M.
  • Cheyne Capital Management (UK) added most to Occidental Petroleum in Q1 2023, an estimated $1.88M increase.
  • Cheyne Capital Management (UK)'s biggest Q1 2023 reduction was Uber, cutting an estimated $292K.
  • Cheyne Capital Management (UK) fully exited Activision Blizzard in Q1 2023, selling an estimated $8.01M.
  • Cheyne Capital Management (UK)'s ten largest holdings make up 82% of its $31.5M portfolio in Q1 2023.
  • Cheyne Capital Management (UK) opened 8 new positions and closed 46 in Q1 2023.
  • Cheyne Capital Management (UK)'s portfolio value fell 45% quarter-over-quarter to $31.5M.

Based on Cheyne Capital Management (UK)'s 13F filing for Q1 2023, filed 3 May 2023.